These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 31220100)

  • 41. Cardiac sympathetic activity and relationship to cardiac events and left ventricular reverse remodeling in patients with non-ischemic dilated cardiomyopathy.
    Mizutani T; Morimoto R; Isobe S; Ito R; Araki T; Kimura Y; Kazama S; Oishi H; Kuwayama T; Hiraiwa H; Kondo T; Okumura T; Murohara T
    Ann Nucl Med; 2023 Aug; 37(8):451-461. PubMed ID: 37273093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic impact of combined late gadolinium enhancement on cardiovascular magnetic resonance and peak oxygen consumption in ambulatory patients with nonischemic dilated cardiomyopathy.
    Yamada T; Hirashiki A; Okumura T; Adachi S; Shimazu S; Shimizu S; Morimoto R; Takeshita K; Naganawa S; Kondo T; Murohara T
    J Card Fail; 2014 Nov; 20(11):825-32. PubMed ID: 25151210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy.
    Ishii S; Inomata T; Fujita T; Iida Y; Ikeda Y; Nabeta T; Yanagisawa T; Naruke T; Mizutani T; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2016 Dec; 31(12):1960-1968. PubMed ID: 26920939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy.
    Fukuoka S; Hayashida K; Hirose Y; Shimotsu Y; Ishida Y; Kakuchi H; Eto T
    Eur J Nucl Med; 1997 May; 24(5):523-9. PubMed ID: 9142733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myocardial 123I-MIBG scintigraphy predicts an impairment in myocardial functional reserve during dobutamine stress in patients with idiopathic dilated cardiomyopathy.
    Ohshima S; Isobe S; Hayashi D; Abe S; Kato K; Murohara T
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):262-70. PubMed ID: 23096078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporal change of myocardial tissue character is associated with left ventricular reverse remodeling in patients with dilated cardiomyopathy: A cardiovascular magnetic resonance study.
    Nabeta T; Inomata T; Fujita T; Iida Y; Ikeda Y; Sato T; Ishii S; Maekawa E; Mizutani T; Naruke T; Koitabashi T; Inoue Y; Ako J
    J Cardiol; 2017 Aug; 70(2):185-191. PubMed ID: 27979675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy parameter predicts cardiac and cerebrovascular events in type 2 diabetic patients without structural heart disease.
    Yufu K; Takahashi N; Okada N; Shinohara T; Nakagawa M; Hara M; Yoshimatsu H; Saikawa T
    Circ J; 2012; 76(2):399-404. PubMed ID: 22130318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis.
    Di Marco A; Anguera I; Schmitt M; Klem I; Neilan TG; White JA; Sramko M; Masci PG; Barison A; Mckenna P; Mordi I; Haugaa KH; Leyva F; Rodriguez Capitán J; Satoh H; Nabeta T; Dallaglio PD; Campbell NG; Sabaté X; Cequier Á
    JACC Heart Fail; 2017 Jan; 5(1):28-38. PubMed ID: 28017348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Right ventricular dysfunction, late gadolinium enhancement, and female gender predict poor outcome in patients with dilated cardiomyopathy.
    Doesch C; Dierks DM; Haghi D; Schimpf R; Kuschyk J; Suselbeck T; Schoenberg SO; Borggrefe M; Papavassiliu T
    Int J Cardiol; 2014 Dec; 177(2):429-35. PubMed ID: 25304065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of perfusion-metabolism mismatch in 99mTc-MIBI and 123I-BMIPP scintigraphy with cardiac magnetic resonance in patients with dilated cardiomyopathy.
    Yoshida A; Takano H; Asai K; Yasutake M; Amano Y; Kumita S; Shimizu W; Mizuno K
    J Card Fail; 2013 Jul; 19(7):445-53. PubMed ID: 23834920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study.
    Yi JE; Park J; Lee HJ; Shin DG; Kim Y; Kim M; Kwon K; Pyun WB; Kim YJ; Joung B
    PLoS One; 2018; 13(11):e0208100. PubMed ID: 30485353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients.
    Ohshima S; Isobe S; Izawa H; Nanasato M; Ando A; Yamada A; Yamada K; Kato TS; Obata K; Noda A; Nishizawa T; Kato K; Nagata K; Okumura K; Murohara T; Yokota M
    J Am Coll Cardiol; 2005 Dec; 46(11):2061-8. PubMed ID: 16325043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Late gadolinium enhancement on cardiac magnetic resonance imaging is associated with coronary endothelial dysfunction in patients with dilated cardiomyopathy.
    Nakayama M; Yamamuro M; Takashio S; Uemura T; Nakayama N; Hirakawa K; Oda S; Utsunomiya D; Kaikita K; Hokimoto S; Yamashita Y; Morita Y; Kimura K; Tamura K; Tsujita K
    Heart Vessels; 2018 Apr; 33(4):393-402. PubMed ID: 29051976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impairment of cardiac neuronal function in childhood dilated cardiomyopathy: an 123I-MIBG scintigraphic study.
    Maunoury C; Agostini D; Acar P; Antonietti T; Sidi D; Bouvard G; Kachaner J; Barritault L
    J Nucl Med; 2000 Mar; 41(3):400-4. PubMed ID: 10716309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver T1 Mapping Derived From Cardiac Magnetic Resonance Imaging: A Potential Prognostic Marker in Idiopathic Dilated Cardiomyopathy.
    Wang J; Diao Y; Xu Y; Guo J; Li W; Li Y; Wan K; Sun J; Han Y; Chen Y
    J Magn Reson Imaging; 2024 Aug; 60(2):675-685. PubMed ID: 38174826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic impact of late gadolinium enhancement at the right ventricular insertion points in non-ischaemic dilated cardiomyopathy.
    Claver E; Di Marco A; Brown PF; Bradley J; Nucifora G; Ruiz-Majoral A; Dallaglio PD; Rodriguez M; Comin-Colet J; Anguera I; Miller CA; Schmitt M
    Eur Heart J Cardiovasc Imaging; 2023 Feb; 24(3):346-353. PubMed ID: 35699462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy.
    Mirelis JG; Escobar-Lopez L; Ochoa JP; Espinosa MÁ; Villacorta E; Navarro M; Casas G; Mora-Ayestarán N; Barriales-Villa R; Mogollón-Jiménez MV; García-Pinilla JM; García-Granja PE; Climent V; Palomino-Doza J; García-Álvarez A; Álvarez-Barredo M; Cabrera-Borrego E; Ripoll-Vera T; Peña-Peña ML; Rodríguez-González E; Gallego-Delgado M; Gonzalez-Carrillo J; Fernández-Ávila A; Rodríguez-Palomares JF; Brugada R; Bayes-Genis A; Dominguez F; García-Pavía P
    Eur J Heart Fail; 2022 Jul; 24(7):1183-1196. PubMed ID: 35485241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging.
    Gao P; Yee R; Gula L; Krahn AD; Skanes A; Leong-Sit P; Klein GJ; Stirrat J; Fine N; Pallaveshi L; Wisenberg G; Thompson TR; Prato F; Drangova M; White JA
    Circ Cardiovasc Imaging; 2012 Jul; 5(4):448-56. PubMed ID: 22572740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.